Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine versus intranasal fentanyl as adjuncts to intravenous ketorolac for renal colic pain relief
IRCT20201028049179N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Renal colic comparing Intranasal ketamine + intravenous ketorolac, Intranasal fentanyl + intravenous ketorolac and Placebo nasal spray + intravenous ketorolac (3 arms). Primary endpoint: Severity of pain measured by Visual Analogue Scale. Started Sep 2020; status: completed.
02
Drugs
ketaminefentanylketorolac
03
Conditions
Renal colic
Beyond the preview
Go deeper on IRCT20201028049179N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201028049179N1.